Raymond James & Associates’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-3,447
| Closed | -$148K | – | 3575 |
|
|
2018
Q2 | $148K | Buy |
3,447
+19
| +0.6% | +$816 | ﹤0.01% | 3309 |
|
|
2018
Q1 | $224K | Buy |
3,428
+142
| +4% | +$9.28K | ﹤0.01% | 3057 |
|
|
2017
Q4 | $240K | Buy |
+3,286
| New | +$240K | ﹤0.01% | 2934 |
|
|
2017
Q1 | – | Sell |
-1,491
| Closed | -$138K | – | 3224 |
|
|
2016
Q4 | $138K | Sell |
1,491
-56
| -4% | -$5.18K | ﹤0.01% | 2944 |
|
|
2016
Q3 | $209K | Sell |
1,547
-155
| -9% | -$20.9K | ﹤0.01% | 2808 |
|
|
2016
Q2 | $173K | Sell |
1,702
-289
| -15% | -$29.4K | ﹤0.01% | 2687 |
|
|
2016
Q1 | $326K | Buy |
1,991
+642
| +48% | +$105K | ﹤0.01% | 2274 |
|
|
2015
Q4 | $442K | Sell |
1,349
-56
| -4% | -$18.3K | ﹤0.01% | 2050 |
|
|
2015
Q3 | $453K | Buy |
1,405
+15
| +1% | +$4.84K | ﹤0.01% | 1963 |
|
|
2015
Q2 | $554K | Buy |
1,390
+94
| +7% | +$37.5K | ﹤0.01% | 2036 |
|
|
2015
Q1 | $638K | Sell |
1,296
-292
| -18% | -$144K | ﹤0.01% | 1916 |
|
|
2014
Q4 | $568K | Sell |
1,588
-296
| -16% | -$106K | ﹤0.01% | 1877 |
|
|
2014
Q3 | $363K | Buy |
1,884
+314
| +20% | +$60.5K | ﹤0.01% | 1961 |
|
|
2014
Q2 | $375K | Sell |
1,570
-56
| -3% | -$13.4K | ﹤0.01% | 1960 |
|
|
2014
Q1 | $416K | Sell |
1,626
-1,022
| -39% | -$261K | ﹤0.01% | 1858 |
|
|
2013
Q4 | $525K | Sell |
2,648
-1,392
| -34% | -$276K | ﹤0.01% | 1644 |
|
|
2013
Q3 | $683K | Sell |
4,040
-33
| -0.8% | -$5.58K | 0.01% | 1445 |
|
|
2013
Q2 | $723K | Buy |
+4,073
| New | +$723K | 0.01% | 1329 |
|